Stephen P Finn


Affiliation: Trinity College
Country: Ireland


  1. O Brien O, Wright M, O Brien C, Geoghegan O, Leonard N, Nicholson S, et al. Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed Paraffin-Embedded (FFPE) Non-Small Cell Lung Cancer (NSCLC) Samples. Diagnostics (Basel). 2019;9: pubmed publisher
    ..In this report, we examine three different methodologies to detect METex14 and assess their potential utility for use as a diagnostic assay for both the identification of METex14 and intra-tumoural distribution in NSCLC. ..
  2. Lim M, Baird A, Aird J, Greene J, Kapoor D, Gray S, et al. RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer-From Cell Line Models to Liquid Biopsies. Diagnostics (Basel). 2018;8: pubmed publisher
    ..This review focuses on the evidence for the role of RNAs in prostate cancer, and their use as diagnostic and prognostic markers, and targets for treatment in this disease. ..
  3. O Grady S, Finn S, Cuffe S, Richard D, O Byrne K, Barr M. The role of DNA repair pathways in cisplatin resistant lung cancer. Cancer Treat Rev. 2014;40:1161-70 pubmed publisher
  4. MacDonagh L, Gray S, Finn S, Cuffe S, O Byrne K, Barr M. The emerging role of microRNAs in resistance to lung cancer treatments. Cancer Treat Rev. 2015;41:160-9 pubmed publisher
    ..In this review, we provide an overview on the role of miRNAs in resistance to current lung cancer therapies and novel biological agents. ..
  5. Stahel R, Bogaerts J, Ciardiello F, De Ruysscher D, Dubsky P, Ducreux M, et al. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development. Cancer Treat Rev. 2015;41:129-35 pubmed publisher
  6. Tonry C, Leacy E, Raso C, Finn S, Armstrong J, Pennington S. The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer. Diagnostics (Basel). 2016;6: pubmed publisher
  7. Heery R, Finn S, Cuffe S, Gray S. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. Cancers (Basel). 2017;9: pubmed publisher